Very Low LeverageZero reported debt materially reduces refinancing and interest-rate risk and preserves financial optionality. Over a 2–6 month horizon this strengthens the firm's ability to negotiate restructuring, access capital markets if needed, and prioritize operational fixes without immediate debt-service pressure.

Improving Cash Burn TrendA reduction in peak cash burn signals management has taken measures to slow outflows, which can extend runway and reduce near-term financing needs. If sustained, this structural improvement supports the firm’s ability to execute turn-around actions and stabilise operations over the medium term.

Historical Revenue Growth Prior To 2024Prior growth in 2022–2023 demonstrates the company has been able to scale demand and suggests some product-market fit or addressable market. That prior traction provides a foundation for recovery initiatives and strategic redeployment of resources if underlying market conditions or execution improve.

Bears Say

Sharp 2024 Revenue Collapse And Negative Gross ProfitA ~74% revenue drop paired with negative gross profit indicates unit economics are broken and costs exceed sales. Structurally, this undermines margin sustainability and means simple volume recovery alone won’t restore profitability; durable remediation requires major cost or business-model changes.

Persistent Negative Operating And Free Cash FlowConsistent negative OCF and FCF show the business systematically consumes cash, necessitating ongoing funding or dilution. This pattern constrains strategic flexibility, increases refinancing and equity-issuance risk, and poses a sustained threat to continuity absent durable cash-generation improvements.

Equity Erosion And Deeply Negative ReturnsSignificant equity contraction and deeply negative ROE reflect cumulative losses that deplete the capital base. This structural deterioration heightens dilution risk, weakens creditor and investor confidence, and makes raising capital on reasonable terms harder, impairing long-term viability.

HUMX.M FAQ

What was Human Xt-M’s price range in the past 12 months?

Human Xt-M lowest stock price was 0.00 and its highest was 40.00 in the past 12 months.

What is Human Xt-M’s market cap?

Human Xt-M’s market cap is ₪5.86M.

When is Human Xt-M’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Human Xt-M’s earnings last quarter?

Human Xt-M released its earnings results on Nov 21, 2024. The company reported -48.9 earnings per share for the quarter, missing the consensus estimate of N/A by -48.9.

Is Human Xt-M overvalued?

According to Wall Street analysts Human Xt-M’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Human Xt-M pay dividends?

Human Xt-M does not currently pay dividends.

What is Human Xt-M’s EPS estimate?

Human Xt-M’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Human Xt-M have?

Human Xt-M has 26,756,048 shares outstanding.

What happened to Human Xt-M’s price movement after its last earnings report?

Human Xt-M reported an EPS of -48.9 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Human Xt-M?

Currently, no hedge funds are holding shares in IL:HUMX.M

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Human Xt-M

Human Xtensions Ltd. develops, manufactures, markets and sells a modular medical device for minimally invasive surgical operations. It offers HandX, a handheld electromechanical device for use in laparoscopic procedures; Fenestrated Grasper; Monopolar Hook; and Needle Holder. The company was incorporated in 2012 and is based in Netanya, Israel.